-
1
المؤلفون: Iwona Lugowska, Paweł Teterycz, Piotr Rutkowski
المصدر: Contemporary Oncology
مصطلحات موضوعية: 0301 basic medicine, Oncology, medicine.medical_specialty, medicine.medical_treatment, Ipilimumab, Pembrolizumab, Cell therapy, 03 medical and health sciences, 0302 clinical medicine, Internal medicine, melanoma, medicine, Radiology, Nuclear Medicine and imaging, Progression-free survival, ipilimumab, nivolumab, Original Paper, business.industry, Melanoma, Immunotherapy, medicine.disease, Oncolytic virus, 030104 developmental biology, 030220 oncology & carcinogenesis, pembrolizumab, Nivolumab, business, medicine.drug
الوصول الحر: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::4f7377821ac7d866280943a2ee89dbc7Test
https://doi.org/10.5114/wo.2018.73889Test -
2
المؤلفون: Marek Ziobro, Bożena Cybulska-Stopa, Iwona Lugowska, Grażyna Kamińska-Winciorek, Piotr Rutkowski
المصدر: Advances in Dermatology and Allergology/Postȩpy Dermatologii i Alergologii
Advances in Dermatology and Allergology, Vol 36, Iss 4, Pp 382-391 (2019)مصطلحات موضوعية: Oncology, medicine.medical_specialty, lcsh:Internal medicine, Durvalumab, medicine.medical_treatment, Ipilimumab, Dermatology, Pembrolizumab, Avelumab, 030207 dermatology & venereal diseases, 03 medical and health sciences, 0302 clinical medicine, Atezolizumab, Internal medicine, medicine, lcsh:Dermatology, Immunology and Allergy, lcsh:RC31-1245, immune checkpoint antibody, Review Paper, business.industry, Cancer, Immunotherapy, lcsh:RL1-803, medicine.disease, skin toxicities, Nivolumab, business, medicine.drug
الوصول الحر: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::3df57b1a709b92f40310ea09378db7c4Test
https://pubmed.ncbi.nlm.nih.gov/31616210Test